Extent, pattern, and reconstruction drive bypass use in renal cancer associated inferior vena cava tumor thrombus surgery: safe outcomes from a single-center retrospective cohort study

Purpose: We aim to present a retrospective surgical review of inferior vena cava tumor thrombus (IVCTT) management, emphasizing when cardiopulmonary/venovenous bypass is warranted and whether minimally invasive approaches are appropriate. Materials and methods: This is a study of a retrospective, single-center cohort (2013–2024) of consecutive Mayo I–IV IVCTT resections ( n = 63). Primary outcomes were overall survival (OS) and disease-free survival (DFS). Perioperative metrics included operative duration, blood loss, complications, intensive care unit (ICU) use, and time to oral intake. Bypass decisions were made by a combined urology–vascular–cardiac anesthesia team based on thrombus pattern (free-floating vs adherent/infiltrative), IVC wall encasement, hepatic/right-atrial extension, and reconstruction design (primary closure vs segmental resection/patch/graft), rather than thrombus level alone. Results: Median operative duration was 450 minutes; median blood loss 1000 ml; ICU care in 15/63. Complications were predominantly Clavien–Dindo grade 1–2 with grade ≥3 occurred in 9.6%; and postoperative mortality was 4.8%. Early oral intake (<2.5 days) and shorter operative duration (<415 minutes) were associated with a superior 5-year OS. Bypass was limited in advanced thrombi with encasement or atrial/hepatic venous involvement, reflecting pattern-based selection and reconstruction needs. Minimally invasive thrombectomy was not adopted except in highly selected, non-encasing patterns. Conclusions: For IVCTT, bypass use should be dictated by thrombus pattern, encasement, and planned reconstruction – not level alone. With such selection, surgery is safe and offers durable control. Minimally invasive strategies fit only a very limited subset.